Leveraging Genetically Engineered Mouse Models of Small Cell Lung Cancer for Advanced Therapeutic St

1 意见
administrator
administrator
07/08/23

Anna Farago, MD
We have developed a series of genetically engineered mouse models of SCLC, in which conditional deletion of the tumor suppressor genes p53 and Rb1 in pulmonary epithelial cells triggers initiation of tumors that mirror the histology

  • 类别

显示更多

0 注释 排序方式

没有找到评论

脸书评论

下一个